No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract: Hyperfractionated radiotherapy with concomitant chemotherapy is highly effective for locally advanced head and neck cancers

byTeddy Guo

May 20, 2021

in StudyGraphics

Reading Time: 1 min read

$#VisualAbstract: Hyperfractionated radiotherapy with concomitant chemotherapy is highly effective for locally advanced head and neck cancers$

Click to read the study in The Lancet Oncology.

RELATED REPORTS

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma

Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy

Cardiovascular safety of hydroxychloroquine in veterans with rheumatoid arthritis

RelatedReports

Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026

Chronic Disease

Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma

September 18, 2026

Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening

Chronic Disease

Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy

September 7, 2026

Long-term outcomes for off-pump and on-pump CABG are similar

Weekly Rewinds

2 Minute Medicine Rewind September 7, 2026

September 7, 2026

Sleep duration inversely related to childhood type 2 diabetes risk makers

Combined cagrilintide and semaglutide for weight management well-tolerated in early clinical trials

$#VisualAbstract Phase 1 trial shows loncastuximab tesirine demonstrated significant response rates and an acceptable safety profile in patients with relapsed/refractory B-cell non-Hodgkin lymphoma$

#VisualAbstract Phase 1 trial shows loncastuximab tesirine demonstrated significant response rates and an acceptable safety profile in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

Esmolol-induced heart rate reduction may aid in septic shock

Survivors of intensive care unit admissions may have increased risk of self-harm and suicide

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Hyperfractionated radiotherapy with concomitant chemotherapy is highly effective for locally advanced head and neck cancers

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma

Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy

Cardiovascular safety of hydroxychloroquine in veterans with rheumatoid arthritis

Combined cagrilintide and semaglutide for weight management well-tolerated in early clinical trials

RelatedReports

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma

Molecularly guided therapy may improve outcomes in patients with unfavourable cancer of unknown primary compared with standard chemotherapy

2 Minute Medicine Rewind September 7, 2026

Combined cagrilintide and semaglutide for weight management well-tolerated in early clinical trials

#VisualAbstract Phase 1 trial shows loncastuximab tesirine demonstrated significant response rates and an acceptable safety profile in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

Survivors of intensive care unit admissions may have increased risk of self-harm and suicide

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits